Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Josh_Mandel-Brehm
|
| gptkbp:developedBy |
RNA Actuating Platform
|
| gptkbp:focusesOn |
gene regulation
RNA therapeutics transcriptional regulation |
| gptkbp:foundedYear |
2016
|
| gptkbp:founder |
gptkb:Richard_Young
gptkb:Rick_Young Leonard Zon |
| gptkbp:fundedBy |
gptkb:Series_B
gptkb:Series_A |
| gptkbp:headquartersLocation |
gptkb:Cambridge,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
CAMP4 Therapeutics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:investor |
gptkb:Andreessen_Horowitz
gptkb:Polaris_Partners gptkb:The_Kraft_Group gptkb:Northpond_Ventures GV (formerly Google Ventures) 4BIO Capital |
| gptkbp:numberOfEmployees |
51-200
|
| gptkbp:specializesIn |
transcriptional machinery modulation
|
| gptkbp:targetMarket |
genetic diseases
rare diseases |
| gptkbp:website |
https://www.camp4tx.com/
|
| gptkbp:bfsParent |
gptkb:Josh_Mandel-Brehm
gptkb:Silvergate_Pharmaceuticals |
| gptkbp:bfsLayer |
8
|